These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3917587)

  • 41. Donor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts.
    Sakamoto T; Ye Q; Lu L; Demetris AJ; Starzl TE; Murase N
    Transplantation; 1999 Mar; 67(6):833-40. PubMed ID: 10199731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa molecules.
    Ghobrial RR; Hamashima T; Wang ME; Wang M; Stepkowski SM; Kahan BD
    Transplantation; 1996 Oct; 62(7):1002-10. PubMed ID: 8878396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of non-RT1 genes in the response of rat lymphocytes to Mycoplasma arthritidis T cell mitogen, concanavalin A and phytohemagglutinin.
    Cole BC; Griffiths MM; Sullivan GJ; Ward JR
    J Immunol; 1986 Apr; 136(7):2364-9. PubMed ID: 3081642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of counterflow centrifugal elutriation for the depletion of T cells from unrelated donor bone marrow.
    Neudorf SM; Rybka W; Ball E; Blatt J; Bloom E; Corey S; deMagalhaes-Silverman M; Koehler M; Lister J; Mierski J; Mirro J; Pincus S; Wilson J; Wollman M; Donnenberg AD
    J Hematother; 1997 Aug; 6(4):351-9. PubMed ID: 9377073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone marrow transplantation in miniature swine: IV. Development of myeloablative regimens that allow engraftment across major histocompatibility barriers.
    Smith CV; Suzuki T; Guzzetta PC; Nakajima K; Sundt TM; Mixon A; Spitzer TR; Eckhaus MA; Sachs DH
    Transplantation; 1993 Sep; 56(3):541-9. PubMed ID: 8212147
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.
    Jäger MD; Liu JY; Timrott KF; Popp FC; Stoeltzing O; Lang SA; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
    Exp Hematol; 2007 Jan; 35(1):164-70. PubMed ID: 17198885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier.
    Siemionow MZ; Klimczak A; Unal S
    Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB; Elkin G; Khitrin S; Slavin S
    Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mesenchymal stromal cells fail to alleviate experimental graft-versus-host disease in rats transplanted with major histocompatibility complex-mismatched bone marrow.
    Zinöcker S; Wang MY; Rolstad B; Vaage JT
    Scand J Immunol; 2012 Nov; 76(5):464-70. PubMed ID: 22803811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of graft-versus-host disease and the induction of transplant tolerance by low-dose UV-B irradiation of BM cells combined with cyclosporine immunosuppression.
    Ohajekwe OA; Hardy MA; Oluwole SF
    Transplantation; 1995 Dec; 60(12):1510-6. PubMed ID: 8545883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A two-phase pathogenesis of graft-versus-host disease in mice.
    van Leeuwen L; Guiffre A; Atkinson K; Rainer SP; Sewell WA
    Bone Marrow Transplant; 2002 Jan; 29(2):151-8. PubMed ID: 11850710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A partial conditioning strategy for achieving mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment.
    Gammie JS; Li S; Colson YL; Demetris AJ; Neipp M; Ildstad ST; Pham SM
    Exp Hematol; 1998 Sep; 26(10):927-35. PubMed ID: 9728927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
    He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bone marrow transplantation in the busulfan-treated rat. I. Effect of cyclophosphamide and rabbit antirat thymocyte serum as immunosuppression.
    Tutschka PJ; Santos GW
    Transplantation; 1975 Aug; 20(2):101-6. PubMed ID: 241143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both.
    Murase N; Ye Q; Nalesnik MA; Demetris AJ; Abu-Elmagd K; Reyes J; Ichikawa N; Okuda T; Fung JJ; Starzl TE
    Transplantation; 2000 Dec; 70(11):1632-41. PubMed ID: 11152226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299.
    Annat J; Churaqui E; Dutartre P; Bruley-Rosset M
    Transplantation; 1996 Sep; 62(6):721-9. PubMed ID: 8824467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of T cell depletion in radiation bone marrow chimeras. I. Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD.
    Sykes M; Sheard M; Sachs DH
    J Immunol; 1988 Oct; 141(7):2282-8. PubMed ID: 3049804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.